As part of our series focusing on how AI is transforming the pharmaceutical and life sciences industry, this article focuses ...

The global active pharmaceutical ingredients market size was worth USD 239.18 billion in 2024 and is expected to reach around USD 368.49 billion by 2033, with a noteworthy CAGR of 5.64% from 2023 to ...

The Pharmaceutical Excipients Market is poised for significant growth between 2025 and 2035, driven by the increasing demand ...

Market OverviewThe Global Breast Cancer Therapeutics Market  remains one of the most prevalent forms of cancer worldwide, ...

A global awareness day aiming to put female innovators at the heart of sustainable development is “a true inspiration to Scottish healthcare’s forward-thinkers,” says a formal NHS partner.

The Global Population Health Management Market was valued at $27.05 billion in 2022 and is projected to reach $70.40 billion ...

ConferenceFirst-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with Pentixapharm’s Lu177-PentixaTher to be Presented at ASCO-GU 2025 13.02.2025 / 14:10 CET/CESTThe issuer is ...

Eleven early-stage companies working in oncology have started ‘Discovery Spark’, a free seven week development programme ...

Market OverviewThe digital health market is revolutionizing the healthcare sector by integrating cutting-edge technologies ...

Alfa Chemistry has made a remarkable stride in the field of synthetic biology with the recent renewal of its oligonucleotide series products. This updated lineup includes a range of advanced ...

A scheduled review of the E.mbrace phase 3 study (clinical trial identifier: NCT04899336) conducted by an independent data monitoring committee (IDMC) determined that Sanofi and Johnson & Johnson’s ...

Genmab A/S (Nasdaq: GMAB) summons the Annual General Meeting on Wednesday, March 12, 2025, at 2:00 PM CET at the Copenhagen Marriott Hotel, Kalvebod Brygge 5, DK-1560 Copenhagen V, Denmark. The notice ...